Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Vinorelbine Market Growth 2022-2028

  • LP 4744380
  • 115 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Vinorelbine will have significant change from previous year. According to our (LP Information) latest study, the global Vinorelbine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Vinorelbine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Vinorelbine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Vinorelbine market, reaching US$ million by the year 2028. As for the Europe Vinorelbine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Vinorelbine players cover Pierre Fabre Pharmaceuticals, Inc., TEVA Pharms, Hospira, Inc., and West-Ward Pharmaceuticals Corp., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Vinorelbine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Oral

Injection

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Breast Cancer

Non-small Cell Lung Cancer

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Pierre Fabre Pharmaceuticals, Inc.

TEVA Pharms

Hospira, Inc.

West-Ward Pharmaceuticals Corp.

Fresenius Kabi

EBEWE Pharma (Sandoz A Novartis Division)

Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

Mylan

Dr. Reddy's Laboratories

Hangzhou Minsheng Pharmaceutical Group Co., Ltd.

Nanjing Cuccess Pharmaceutical Co., Ltd

Qilu Pharmaceutical (Hainan) Co., Ltd.

Sinopharm A-Think Pharmaceutical Co., Ltd.

Beijing SL Pharm

Shenzhen Main Luck Pharmaceuticals Inc.

Shanxi Powerdone Pharmaceutics Co., Ltd.

Luoxin Pharmaceutical Group Co., Ltd.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Vinorelbine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Vinorelbine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Vinorelbine by Country/Region, 2017, 2022 & 2028

2.2 Vinorelbine Segment by Type

2.2.1 Oral

2.2.2 Injection

2.3 Vinorelbine Sales by Type

2.3.1 Global Vinorelbine Sales Market Share by Type (2017-2022)

2.3.2 Global Vinorelbine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Vinorelbine Sale Price by Type (2017-2022)

2.4 Vinorelbine Segment by Application

2.4.1 Breast Cancer

2.4.2 Non-small Cell Lung Cancer

2.4.3 Other

2.5 Vinorelbine Sales by Application

2.5.1 Global Vinorelbine Sale Market Share by Application (2017-2022)

2.5.2 Global Vinorelbine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Vinorelbine Sale Price by Application (2017-2022)

3 Global Vinorelbine by Company

3.1 Global Vinorelbine Breakdown Data by Company

3.1.1 Global Vinorelbine Annual Sales by Company (2020-2022)

3.1.2 Global Vinorelbine Sales Market Share by Company (2020-2022)

3.2 Global Vinorelbine Annual Revenue by Company (2020-2022)

3.2.1 Global Vinorelbine Revenue by Company (2020-2022)

3.2.2 Global Vinorelbine Revenue Market Share by Company (2020-2022)

3.3 Global Vinorelbine Sale Price by Company

3.4 Key Manufacturers Vinorelbine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Vinorelbine Product Location Distribution

3.4.2 Players Vinorelbine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Vinorelbine by Geographic Region

4.1 World Historic Vinorelbine Market Size by Geographic Region (2017-2022)

4.1.1 Global Vinorelbine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Vinorelbine Annual Revenue by Geographic Region

4.2 World Historic Vinorelbine Market Size by Country/Region (2017-2022)

4.2.1 Global Vinorelbine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Vinorelbine Annual Revenue by Country/Region

4.3 Americas Vinorelbine Sales Growth

4.4 APAC Vinorelbine Sales Growth

4.5 Europe Vinorelbine Sales Growth

4.6 Middle East & Africa Vinorelbine Sales Growth

5 Americas

5.1 Americas Vinorelbine Sales by Country

5.1.1 Americas Vinorelbine Sales by Country (2017-2022)

5.1.2 Americas Vinorelbine Revenue by Country (2017-2022)

5.2 Americas Vinorelbine Sales by Type

5.3 Americas Vinorelbine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Vinorelbine Sales by Region

6.1.1 APAC Vinorelbine Sales by Region (2017-2022)

6.1.2 APAC Vinorelbine Revenue by Region (2017-2022)

6.2 APAC Vinorelbine Sales by Type

6.3 APAC Vinorelbine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Vinorelbine by Country

7.1.1 Europe Vinorelbine Sales by Country (2017-2022)

7.1.2 Europe Vinorelbine Revenue by Country (2017-2022)

7.2 Europe Vinorelbine Sales by Type

7.3 Europe Vinorelbine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Vinorelbine by Country

8.1.1 Middle East & Africa Vinorelbine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Vinorelbine Revenue by Country (2017-2022)

8.2 Middle East & Africa Vinorelbine Sales by Type

8.3 Middle East & Africa Vinorelbine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Vinorelbine

10.3 Manufacturing Process Analysis of Vinorelbine

10.4 Industry Chain Structure of Vinorelbine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Vinorelbine Distributors

11.3 Vinorelbine Customer

12 World Forecast Review for Vinorelbine by Geographic Region

12.1 Global Vinorelbine Market Size Forecast by Region

12.1.1 Global Vinorelbine Forecast by Region (2023-2028)

12.1.2 Global Vinorelbine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Vinorelbine Forecast by Type

12.7 Global Vinorelbine Forecast by Application

13 Key Players Analysis

13.1 Pierre Fabre Pharmaceuticals, Inc.

13.1.1 Pierre Fabre Pharmaceuticals, Inc. Company Information

13.1.2 Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Product Offered

13.1.3 Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pierre Fabre Pharmaceuticals, Inc. Main Business Overview

13.1.5 Pierre Fabre Pharmaceuticals, Inc. Latest Developments

13.2 TEVA Pharms

13.2.1 TEVA Pharms Company Information

13.2.2 TEVA Pharms Vinorelbine Product Offered

13.2.3 TEVA Pharms Vinorelbine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 TEVA Pharms Main Business Overview

13.2.5 TEVA Pharms Latest Developments

13.3 Hospira, Inc.

13.3.1 Hospira, Inc. Company Information

13.3.2 Hospira, Inc. Vinorelbine Product Offered

13.3.3 Hospira, Inc. Vinorelbine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Hospira, Inc. Main Business Overview

13.3.5 Hospira, Inc. Latest Developments

13.4 West-Ward Pharmaceuticals Corp.

13.4.1 West-Ward Pharmaceuticals Corp. Company Information

13.4.2 West-Ward Pharmaceuticals Corp. Vinorelbine Product Offered

13.4.3 West-Ward Pharmaceuticals Corp. Vinorelbine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 West-Ward Pharmaceuticals Corp. Main Business Overview

13.4.5 West-Ward Pharmaceuticals Corp. Latest Developments

13.5 Fresenius Kabi

13.5.1 Fresenius Kabi Company Information

13.5.2 Fresenius Kabi Vinorelbine Product Offered

13.5.3 Fresenius Kabi Vinorelbine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Fresenius Kabi Main Business Overview

13.5.5 Fresenius Kabi Latest Developments

13.6 EBEWE Pharma (Sandoz A Novartis Division)

13.6.1 EBEWE Pharma (Sandoz A Novartis Division) Company Information

13.6.2 EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Product Offered

13.6.3 EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 EBEWE Pharma (Sandoz A Novartis Division) Main Business Overview

13.6.5 EBEWE Pharma (Sandoz A Novartis Division) Latest Developments

13.7 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

13.7.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Company Information

13.7.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Product Offered

13.7.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Main Business Overview

13.7.5 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Latest Developments

13.8 Mylan

13.8.1 Mylan Company Information

13.8.2 Mylan Vinorelbine Product Offered

13.8.3 Mylan Vinorelbine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Mylan Main Business Overview

13.8.5 Mylan Latest Developments

13.9 Dr. Reddy's Laboratories

13.9.1 Dr. Reddy's Laboratories Company Information

13.9.2 Dr. Reddy's Laboratories Vinorelbine Product Offered

13.9.3 Dr. Reddy's Laboratories Vinorelbine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Dr. Reddy's Laboratories Main Business Overview

13.9.5 Dr. Reddy's Laboratories Latest Developments

13.10 Hangzhou Minsheng Pharmaceutical Group Co., Ltd.

13.10.1 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Company Information

13.10.2 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Product Offered

13.10.3 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Main Business Overview

13.10.5 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Latest Developments

13.11 Nanjing Cuccess Pharmaceutical Co., Ltd

13.11.1 Nanjing Cuccess Pharmaceutical Co., Ltd Company Information

13.11.2 Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Product Offered

13.11.3 Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Nanjing Cuccess Pharmaceutical Co., Ltd Main Business Overview

13.11.5 Nanjing Cuccess Pharmaceutical Co., Ltd Latest Developments

13.12 Qilu Pharmaceutical (Hainan) Co., Ltd.

13.12.1 Qilu Pharmaceutical (Hainan) Co., Ltd. Company Information

13.12.2 Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Product Offered

13.12.3 Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Qilu Pharmaceutical (Hainan) Co., Ltd. Main Business Overview

13.12.5 Qilu Pharmaceutical (Hainan) Co., Ltd. Latest Developments

13.13 Sinopharm A-Think Pharmaceutical Co., Ltd.

13.13.1 Sinopharm A-Think Pharmaceutical Co., Ltd. Company Information

13.13.2 Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Product Offered

13.13.3 Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Sinopharm A-Think Pharmaceutical Co., Ltd. Main Business Overview

13.13.5 Sinopharm A-Think Pharmaceutical Co., Ltd. Latest Developments

13.14 Beijing SL Pharm

13.14.1 Beijing SL Pharm Company Information

13.14.2 Beijing SL Pharm Vinorelbine Product Offered

13.14.3 Beijing SL Pharm Vinorelbine Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Beijing SL Pharm Main Business Overview

13.14.5 Beijing SL Pharm Latest Developments

13.15 Shenzhen Main Luck Pharmaceuticals Inc.

13.15.1 Shenzhen Main Luck Pharmaceuticals Inc. Company Information

13.15.2 Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Product Offered

13.15.3 Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Shenzhen Main Luck Pharmaceuticals Inc. Main Business Overview

13.15.5 Shenzhen Main Luck Pharmaceuticals Inc. Latest Developments

13.16 Shanxi Powerdone Pharmaceutics Co., Ltd.

13.16.1 Shanxi Powerdone Pharmaceutics Co., Ltd. Company Information

13.16.2 Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Product Offered

13.16.3 Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Shanxi Powerdone Pharmaceutics Co., Ltd. Main Business Overview

13.16.5 Shanxi Powerdone Pharmaceutics Co., Ltd. Latest Developments

13.17 Luoxin Pharmaceutical Group Co., Ltd.

13.17.1 Luoxin Pharmaceutical Group Co., Ltd. Company Information

13.17.2 Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Product Offered

13.17.3 Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Luoxin Pharmaceutical Group Co., Ltd. Main Business Overview

13.17.5 Luoxin Pharmaceutical Group Co., Ltd. Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Vinorelbine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Vinorelbine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Oral

Table 4. Major Players of Injection

Table 5. Global Vinorelbine Sales by Type (2017-2022) & (MT)

Table 6. Global Vinorelbine Sales Market Share by Type (2017-2022)

Table 7. Global Vinorelbine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Vinorelbine Revenue Market Share by Type (2017-2022)

Table 9. Global Vinorelbine Sale Price by Type (2017-2022) & (USD/Kg)

Table 10. Global Vinorelbine Sales by Application (2017-2022) & (MT)

Table 11. Global Vinorelbine Sales Market Share by Application (2017-2022)

Table 12. Global Vinorelbine Revenue by Application (2017-2022)

Table 13. Global Vinorelbine Revenue Market Share by Application (2017-2022)

Table 14. Global Vinorelbine Sale Price by Application (2017-2022) & (USD/Kg)

Table 15. Global Vinorelbine Sales by Company (2020-2022) & (MT)

Table 16. Global Vinorelbine Sales Market Share by Company (2020-2022)

Table 17. Global Vinorelbine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Vinorelbine Revenue Market Share by Company (2020-2022)

Table 19. Global Vinorelbine Sale Price by Company (2020-2022) & (USD/Kg)

Table 20. Key Manufacturers Vinorelbine Producing Area Distribution and Sales Area

Table 21. Players Vinorelbine Products Offered

Table 22. Vinorelbine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Vinorelbine Sales by Geographic Region (2017-2022) & (MT)

Table 26. Global Vinorelbine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Vinorelbine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Vinorelbine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Vinorelbine Sales by Country/Region (2017-2022) & (MT)

Table 30. Global Vinorelbine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Vinorelbine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Vinorelbine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Vinorelbine Sales by Country (2017-2022) & (MT)

Table 34. Americas Vinorelbine Sales Market Share by Country (2017-2022)

Table 35. Americas Vinorelbine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Vinorelbine Revenue Market Share by Country (2017-2022)

Table 37. Americas Vinorelbine Sales by Type (2017-2022) & (MT)

Table 38. Americas Vinorelbine Sales Market Share by Type (2017-2022)

Table 39. Americas Vinorelbine Sales by Application (2017-2022) & (MT)

Table 40. Americas Vinorelbine Sales Market Share by Application (2017-2022)

Table 41. APAC Vinorelbine Sales by Region (2017-2022) & (MT)

Table 42. APAC Vinorelbine Sales Market Share by Region (2017-2022)

Table 43. APAC Vinorelbine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Vinorelbine Revenue Market Share by Region (2017-2022)

Table 45. APAC Vinorelbine Sales by Type (2017-2022) & (MT)

Table 46. APAC Vinorelbine Sales Market Share by Type (2017-2022)

Table 47. APAC Vinorelbine Sales by Application (2017-2022) & (MT)

Table 48. APAC Vinorelbine Sales Market Share by Application (2017-2022)

Table 49. Europe Vinorelbine Sales by Country (2017-2022) & (MT)

Table 50. Europe Vinorelbine Sales Market Share by Country (2017-2022)

Table 51. Europe Vinorelbine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Vinorelbine Revenue Market Share by Country (2017-2022)

Table 53. Europe Vinorelbine Sales by Type (2017-2022) & (MT)

Table 54. Europe Vinorelbine Sales Market Share by Type (2017-2022)

Table 55. Europe Vinorelbine Sales by Application (2017-2022) & (MT)

Table 56. Europe Vinorelbine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Vinorelbine Sales by Country (2017-2022) & (MT)

Table 58. Middle East & Africa Vinorelbine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Vinorelbine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Vinorelbine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Vinorelbine Sales by Type (2017-2022) & (MT)

Table 62. Middle East & Africa Vinorelbine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Vinorelbine Sales by Application (2017-2022) & (MT)

Table 64. Middle East & Africa Vinorelbine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Vinorelbine

Table 66. Key Market Challenges & Risks of Vinorelbine

Table 67. Key Industry Trends of Vinorelbine

Table 68. Vinorelbine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Vinorelbine Distributors List

Table 71. Vinorelbine Customer List

Table 72. Global Vinorelbine Sales Forecast by Region (2023-2028) & (MT)

Table 73. Global Vinorelbine Sales Market Forecast by Region

Table 74. Global Vinorelbine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Vinorelbine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Vinorelbine Sales Forecast by Country (2023-2028) & (MT)

Table 77. Americas Vinorelbine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Vinorelbine Sales Forecast by Region (2023-2028) & (MT)

Table 79. APAC Vinorelbine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Vinorelbine Sales Forecast by Country (2023-2028) & (MT)

Table 81. Europe Vinorelbine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Vinorelbine Sales Forecast by Country (2023-2028) & (MT)

Table 83. Middle East & Africa Vinorelbine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Vinorelbine Sales Forecast by Type (2023-2028) & (MT)

Table 85. Global Vinorelbine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Vinorelbine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Vinorelbine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Vinorelbine Sales Forecast by Application (2023-2028) & (MT)

Table 89. Global Vinorelbine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Vinorelbine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Vinorelbine Revenue Market Share Forecast by Application (2023-2028)

Table 92. Pierre Fabre Pharmaceuticals, Inc. Basic Information, Vinorelbine Manufacturing Base, Sales Area and Its Competitors

Table 93. Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Product Offered

Table 94. Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 95. Pierre Fabre Pharmaceuticals, Inc. Main Business

Table 96. Pierre Fabre Pharmaceuticals, Inc. Latest Developments

Table 97. TEVA Pharms Basic Information, Vinorelbine Manufacturing Base, Sales Area and Its Competitors

Table 98. TEVA Pharms Vinorelbine Product Offered

Table 99. TEVA Pharms Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 100. TEVA Pharms Main Business

Table 101. TEVA Pharms Latest Developments

Table 102. Hospira, Inc. Basic Information, Vinorelbine Manufacturing Base, Sales Area and Its Competitors

Table 103. Hospira, Inc. Vinorelbine Product Offered

Table 104. Hospira, Inc. Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 105. Hospira, Inc. Main Business

Table 106. Hospira, Inc. Latest Developments

Table 107. West-Ward Pharmaceuticals Corp. Basic Information, Vinorelbine Manufacturing Base, Sales Area and Its Competitors

Table 108. West-Ward Pharmaceuticals Corp. Vinorelbine Product Offered

Table 109. West-Ward Pharmaceuticals Corp. Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 110. West-Ward Pharmaceuticals Corp. Main Business

Table 111. West-Ward Pharmaceuticals Corp. Latest Developments

Table 112. Fresenius Kabi Basic Information, Vinorelbine Manufacturing Base, Sales Area and Its Competitors

Table 113. Fresenius Kabi Vinorelbine Product Offered

Table 114. Fresenius Kabi Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 115. Fresenius Kabi Main Business

Table 116. Fresenius Kabi Latest Developments

Table 117. EBEWE Pharma (Sandoz A Novartis Division) Basic Information, Vinorelbine Manufacturing Base, Sales Area and Its Competitors

Table 118. EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Product Offered

Table 119. EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 120. EBEWE Pharma (Sandoz A Novartis Division) Main Business

Table 121. EBEWE Pharma (Sandoz A Novartis Division) Latest Developments

Table 122. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Basic Information, Vinorelbine Manufacturing Base, Sales Area and Its Competitors

Table 123. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Product Offered

Table 124. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 125. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Main Business

Table 126. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Latest Developments

Table 127. Mylan Basic Information, Vinorelbine Manufacturing Base, Sales Area and Its Competitors

Table 128. Mylan Vinorelbine Product Offered

Table 129. Mylan Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 130. Mylan Main Business

Table 131. Mylan Latest Developments

Table 132. Dr. Reddy's Laboratories Basic Information, Vinorelbine Manufacturing Base, Sales Area and Its Competitors

Table 133. Dr. Reddy's Laboratories Vinorelbine Product Offered

Table 134. Dr. Reddy's Laboratories Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 135. Dr. Reddy's Laboratories Main Business

Table 136. Dr. Reddy's Laboratories Latest Developments

Table 137. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Basic Information, Vinorelbine Manufacturing Base, Sales Area and Its Competitors

Table 138. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Product Offered

Table 139. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 140. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Main Business

Table 141. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Latest Developments

Table 142. Nanjing Cuccess Pharmaceutical Co., Ltd Basic Information, Vinorelbine Manufacturing Base, Sales Area and Its Competitors

Table 143. Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Product Offered

Table 144. Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 145. Nanjing Cuccess Pharmaceutical Co., Ltd Main Business

Table 146. Nanjing Cuccess Pharmaceutical Co., Ltd Latest Developments

Table 147. Qilu Pharmaceutical (Hainan) Co., Ltd. Basic Information, Vinorelbine Manufacturing Base, Sales Area and Its Competitors

Table 148. Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Product Offered

Table 149. Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 150. Qilu Pharmaceutical (Hainan) Co., Ltd. Main Business

Table 151. Qilu Pharmaceutical (Hainan) Co., Ltd. Latest Developments

Table 152. Sinopharm A-Think Pharmaceutical Co., Ltd. Basic Information, Vinorelbine Manufacturing Base, Sales Area and Its Competitors

Table 153. Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Product Offered

Table 154. Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 155. Sinopharm A-Think Pharmaceutical Co., Ltd. Main Business

Table 156. Sinopharm A-Think Pharmaceutical Co., Ltd. Latest Developments

Table 157. Beijing SL Pharm Basic Information, Vinorelbine Manufacturing Base, Sales Area and Its Competitors

Table 158. Beijing SL Pharm Vinorelbine Product Offered

Table 159. Beijing SL Pharm Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 160. Beijing SL Pharm Main Business

Table 161. Beijing SL Pharm Latest Developments

Table 162. Shenzhen Main Luck Pharmaceuticals Inc. Basic Information, Vinorelbine Manufacturing Base, Sales Area and Its Competitors

Table 163. Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Product Offered

Table 164. Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 165. Shenzhen Main Luck Pharmaceuticals Inc. Main Business

Table 166. Shenzhen Main Luck Pharmaceuticals Inc. Latest Developments

Table 167. Shanxi Powerdone Pharmaceutics Co., Ltd. Basic Information, Vinorelbine Manufacturing Base, Sales Area and Its Competitors

Table 168. Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Product Offered

Table 169. Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 170. Shanxi Powerdone Pharmaceutics Co., Ltd. Main Business

Table 171. Shanxi Powerdone Pharmaceutics Co., Ltd. Latest Developments

Table 172. Luoxin Pharmaceutical Group Co., Ltd. Basic Information, Vinorelbine Manufacturing Base, Sales Area and Its Competitors

Table 173. Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Product Offered

Table 174. Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 175. Luoxin Pharmaceutical Group Co., Ltd. Main Business

Table 176. Luoxin Pharmaceutical Group Co., Ltd. Latest Developments

List of Figures

Figure 1. Picture of Vinorelbine

Figure 2. Vinorelbine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Vinorelbine Sales Growth Rate 2017-2028 (MT)

Figure 7. Global Vinorelbine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Vinorelbine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Oral

Figure 10. Product Picture of Injection

Figure 11. Global Vinorelbine Sales Market Share by Type in 2021

Figure 12. Global Vinorelbine Revenue Market Share by Type (2017-2022)

Figure 13. Vinorelbine Consumed in Breast Cancer

Figure 14. Global Vinorelbine Market: Breast Cancer (2017-2022) & (MT)

Figure 15. Vinorelbine Consumed in Non-small Cell Lung Cancer

Figure 16. Global Vinorelbine Market: Non-small Cell Lung Cancer (2017-2022) & (MT)

Figure 17. Vinorelbine Consumed in Other

Figure 18. Global Vinorelbine Market: Other (2017-2022) & (MT)

Figure 19. Global Vinorelbine Sales Market Share by Application (2017-2022)

Figure 20. Global Vinorelbine Revenue Market Share by Application in 2021

Figure 21. Vinorelbine Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Vinorelbine Revenue Market Share by Company in 2021

Figure 23. Global Vinorelbine Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Vinorelbine Revenue Market Share by Geographic Region in 2021

Figure 25. Global Vinorelbine Sales Market Share by Region (2017-2022)

Figure 26. Global Vinorelbine Revenue Market Share by Country/Region in 2021

Figure 27. Americas Vinorelbine Sales 2017-2022 (MT)

Figure 28. Americas Vinorelbine Revenue 2017-2022 ($ Millions)

Figure 29. APAC Vinorelbine Sales 2017-2022 (MT)

Figure 30. APAC Vinorelbine Revenue 2017-2022 ($ Millions)

Figure 31. Europe Vinorelbine Sales 2017-2022 (MT)

Figure 32. Europe Vinorelbine Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Vinorelbine Sales 2017-2022 (MT)

Figure 34. Middle East & Africa Vinorelbine Revenue 2017-2022 ($ Millions)

Figure 35. Americas Vinorelbine Sales Market Share by Country in 2021

Figure 36. Americas Vinorelbine Revenue Market Share by Country in 2021

Figure 37. United States Vinorelbine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Vinorelbine Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Vinorelbine Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Vinorelbine Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Vinorelbine Sales Market Share by Region in 2021

Figure 42. APAC Vinorelbine Revenue Market Share by Regions in 2021

Figure 43. China Vinorelbine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Vinorelbine Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Vinorelbine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Vinorelbine Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Vinorelbine Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Vinorelbine Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Vinorelbine Sales Market Share by Country in 2021

Figure 50. Europe Vinorelbine Revenue Market Share by Country in 2021

Figure 51. Germany Vinorelbine Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Vinorelbine Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Vinorelbine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Vinorelbine Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Vinorelbine Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Vinorelbine Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Vinorelbine Revenue Market Share by Country in 2021

Figure 58. Egypt Vinorelbine Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Vinorelbine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Vinorelbine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Vinorelbine Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Vinorelbine Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Vinorelbine in 2021

Figure 64. Manufacturing Process Analysis of Vinorelbine

Figure 65. Industry Chain Structure of Vinorelbine

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390